Collaboration is key to our success. Explore what we’re saying, what we’re sharing and what we’re thinking.
Does helping to make life better for millions of people motivate you? If you want to make your mark in a growing healthcare company, find out about...
We design and supply medical solutions to enhance performance in healthcare – from the hospital to the home.
The longer a wound remains undisturbed, the better chance it has of healing without complication.
Molnlycke Advantage is a customised learning hub for wound care professionals.
Read news and updates about our company.
Mölnlycke News
Closed Incision Negative Pressure Wound Therapy: A literature review and an introduction to Avance Solo
A supplement, authored by Phil Davies, Senior Global Medical Affairs Manager at Mölnlycke Healthcare, presenting a literature review on Closed Incision...
Mölnlycke® inaugurates new plant and accelerates to meet future demand for supply and sustainability
In its pursuit of sustainable growth and to meet future demands for supply and sustainability Mölnlycke has inaugurated a new surgical gloves factory in...
Mölnlycke Health Care is announced as new Founding Partner for GoCo Arena
Last spring, Mölnlycke Health Care announced that they will move to an entire new headquarter in GoCo Health Innovation City. The 16,000 square meter...
Karl-Henrik Sundström appointed Chair of the Board of Mölnlycke
Karl-Henrik Sundström, professional board member and, among others, former CEO of Stora Enso and CFO of Ericsson, has been appointed new Chair of the...
Mölnlycke invests EUR 50 million in a new surgical gloves plant to meet future demand on supply and sustainability
Mölnlycke ® is investing EUR 50 million in a new plant in Kulim, Malaysia, to meet future demand for high-quality surgical gloves. The new plant will...
Mölnlycke breaks ground for its new headquarters at GoCo Health Innovation City
Today, Mölnlycke joins the groundbreaking ceremony marking the start of construction for their future headquarters at GoCo Health Innovation City. “This...
Mölnlycke announces price increases
Despite the fact that Mölnlycke has introduced a number of measures, the current global macro-economic challenges are now forcing us to raise prices....
Mepilex Ag in the management of partial-thickness burns: A review of the clinical evidence
Pawlak, U., Davies, P., Wounds International 2022
Mölnlycke publishes 2021 Annual and Sustainability report
Mölnlycke’s integrated Annual and Sustainability Report is now available for download, outlining the company’s results and performance in 2021.
Mölnlycke wins Red Dot Award: Product Design 2022
Facial Pressure Injuries (PI) caused by extended use of medical devices have long been a burden for patients and difficult for health care professionals...
Mölnlycke have been awarded a silver medal for sustainability
The world’s largest and most trusted provider of business sustainability ratings - EcoVadis, has awarded Mölnlycke a silver medal for our focus on...
Regarding the tragic events in Ukraine
We are deeply concerned about the current security situation in Europe and fully acknowledge the gravity and tragedy of events in Ukraine. While Mölnlyc...
Mölnlycke to relocate HQ to GoCo Health Innovation City
In late 2024 Mölnlycke will relocate to brand new headquarters in GoCo Health Innovation City in Mölndal. The new headquarters will have a total area of...
Mölnlycke to advance wound care with new technology
We design and supply medical solutions to enhance performance at every point of care – from the operating room to the home. Now we are gearing up for a...
Barry McBride to take on the position as interim CEO
Gothenburg – 24 July 2020 Barry McBride, EVP Gloves, Antiseptics and Global R&D, will take on the role as interim CEO as of 1 August and until the new...
Mölnlycke acquires German wound care company SastoMed GmbH
The world-leading medical solutions company, Mölnlycke, has acquired German wound care products company, SastoMed GmbH. The deal adds new, award-winning...
Creating opportunities at AZ BioVenture Hub
Just a few months since Mölnlycke signed a partnership with AstraZeneca BioVenture Hub, and it has already resulted in collaboration and building...
